Citation

Stefanidou M, Athanaselis S, Spiliopoulou C, Dona A, Maravelias C. Int. J. Clin. Pract. 2010; 64(12): 1712-1718.

Affiliation

Department of Forensic Medicine and Toxicology, Medical School, University of Athens, Athens, Greece. mstefan@med.uoa.gr

Copyright

(Copyright © 2010, John Wiley and Sons)

DOI

10.1111/j.1742-1241.2010.02373.x

PMID

20946276

Abstract

The interpretation of toxicological findings is critical for the thorough investigation of the use and abuse of psychoactive substances. A positive analytical result for a sample taken could usually result in criminal proceedings and a punitive outcome for the defendant whose sample was analysed. The detection of markers of illicit opiate misuse is important both in the management of substance misuse and in the postmortem identification of illicit opiate use. The aim of this study was to emphasise the role of opiate biomarkers available at the laboratory and in the clinical environment. Urine remains the biological tool of choice for qualitative detection of illicit drug use in a clinical setting, while quantitative accuracy remains strictly the domain of blood. Accurate interpretation of the screening tests within a clinical setting alongside other relevant information remains the key to the usefulness of any test. Moreover, the finding of a morphine/codeine concentration ratio in blood exceeding unity is a strong evidence that the person had used heroin, as opposed to having taken a prescription analgesic drug containing codeine.

Language: en